{"id":"https://openalex.org/W2752869939","doi":"https://doi.org/10.1016/j.humimm.2017.06.256","title":"P196 Quantizinghla-class-II (HLACII) peptidomic parameters as immunologically-relevantendophenotypes toimproveimmunogenicity risk prediction for protein therapeutics (\u201cBiologics\u201d) using factor(F) VIII inhibitor development in hemophilia a (HA) as a model","display_name":"P196 Quantizinghla-class-II (HLACII) peptidomic parameters as immunologically-relevantendophenotypes toimproveimmunogenicity risk prediction for protein therapeutics (\u201cBiologics\u201d) using factor(F) VIII inhibitor development in hemophilia a (HA) as a model","publication_year":2017,"publication_date":"2017-09-01","ids":{"openalex":"https://openalex.org/W2752869939","doi":"https://doi.org/10.1016/j.humimm.2017.06.256","mag":"2752869939"},"language":"en","primary_location":{"id":"doi:10.1016/j.humimm.2017.06.256","doi":"https://doi.org/10.1016/j.humimm.2017.06.256","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.humimm.2017.06.256","pdf_url":null,"source":{"id":"https://openalex.org/S6860681","display_name":"Human Immunology","issn_l":"0198-8859","issn":["0198-8859","1879-1166"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Immunology","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","is_traditional":false,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5102803264","display_name":"Vincent P. Diego","orcid":"https://orcid.org/0009-0008-3735-6912","observed_orcids":["https://orcid.org/0009-0008-3735-6912"]},"institutions":[{"id":"https://openalex.org/I2802326326","display_name":"The University of Texas Rio Grande Valley","ror":"https://ror.org/02p5xjf12","country_code":"US","type":"education","lineage":["https://openalex.org/I2802326326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"V. Diego","raw_affiliation_strings":["University of Texas Rio Grande Valley School of Medicine, South Texas Diabetes & Obesity Institute, Brownsville, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Rio Grande Valley School of Medicine, South Texas Diabetes & Obesity Institute, Brownsville, TX, United States","institution_ids":["https://openalex.org/I2802326326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002140151","display_name":"Bernadette W. Luu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2802326326","display_name":"The University of Texas Rio Grande Valley","ror":"https://ror.org/02p5xjf12","country_code":"US","type":"education","lineage":["https://openalex.org/I2802326326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"B. Luu","raw_affiliation_strings":["University of Texas Rio Grande Valley School of Medicine, South Texas Diabetes & Obesity Institute, Brownsville, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Rio Grande Valley School of Medicine, South Texas Diabetes & Obesity Institute, Brownsville, TX, United States","institution_ids":["https://openalex.org/I2802326326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019772996","display_name":"Marcio Almeida","orcid":"https://orcid.org/0000-0002-8114-3892","observed_orcids":["https://orcid.org/0000-0002-8114-3892"]},"institutions":[{"id":"https://openalex.org/I2802326326","display_name":"The University of Texas Rio Grande Valley","ror":"https://ror.org/02p5xjf12","country_code":"US","type":"education","lineage":["https://openalex.org/I2802326326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Almeida","raw_affiliation_strings":["University of Texas Rio Grande Valley School of Medicine, South Texas Diabetes & Obesity Institute, Brownsville, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Rio Grande Valley School of Medicine, South Texas Diabetes & Obesity Institute, Brownsville, TX, United States","institution_ids":["https://openalex.org/I2802326326"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Hofmann","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Hofmann","raw_affiliation_strings":["CSL Behring GmbH, Research, Marburg, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CSL Behring GmbH, Research, Marburg, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031601471","display_name":"Jose Antonio G. Hernandez","orcid":"https://orcid.org/0000-0002-2645-0523","observed_orcids":["https://orcid.org/0000-0002-2645-0523"]},"institutions":[{"id":"https://openalex.org/I2802326326","display_name":"The University of Texas Rio Grande Valley","ror":"https://ror.org/02p5xjf12","country_code":"US","type":"education","lineage":["https://openalex.org/I2802326326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Hernandez","raw_affiliation_strings":["University of Texas Rio Grande Valley School of Medicine, South Texas Diabetes & Obesity Institute, Brownsville, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Rio Grande Valley School of Medicine, South Texas Diabetes & Obesity Institute, Brownsville, TX, United States","institution_ids":["https://openalex.org/I2802326326"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076105158","display_name":"Adriana Baz Morelli","orcid":"https://orcid.org/0000-0002-5172-8849","observed_orcids":["https://orcid.org/0000-0002-5172-8849"]},"institutions":[{"id":"https://openalex.org/I4210153402","display_name":"CSL (Australia)","ror":"https://ror.org/044tc0x05","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210153402"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"A. Morelli","raw_affiliation_strings":["CSL Limited, Research, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CSL Limited, Research, Melbourne, Australia","institution_ids":["https://openalex.org/I4210153402"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081907928","display_name":"Afshin Ameri","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I25041050","display_name":"Augusta University","ror":"https://ror.org/012mef835","country_code":"US","type":"education","lineage":["https://openalex.org/I25041050"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"A. Ameri","raw_affiliation_strings":["Medical College of Georgia, Augusta University, Children\u2019s Hospital of Georgia, Division of Pediatric Hematology and Oncology, Augusta, GA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical College of Georgia, Augusta University, Children\u2019s Hospital of Georgia, Division of Pediatric Hematology and Oncology, Augusta, GA, United States","institution_ids":["https://openalex.org/I25041050"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022788429","display_name":"Raja Rajalingam","orcid":"https://orcid.org/0000-0001-8821-7877","observed_orcids":["https://orcid.org/0000-0001-8821-7877"]},"institutions":[{"id":"https://openalex.org/I180670191","display_name":"University of California, San Francisco","ror":"https://ror.org/043mz5j54","country_code":"US","type":"education","lineage":["https://openalex.org/I180670191"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"R. Rajalingam","raw_affiliation_strings":["University of California San Francisco, Immunogenetics and Transplantation Laboratory, San Francisco, CA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of California San Francisco, Immunogenetics and Transplantation Laboratory, San Francisco, CA, United States","institution_ids":["https://openalex.org/I180670191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5108785086","display_name":"Jerry Sherman Powell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112753","display_name":"CSL (United States)","ror":"https://ror.org/01jxhxv92","country_code":"US","type":"company","lineage":["https://openalex.org/I4210112753","https://openalex.org/I4210153402"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Powell","raw_affiliation_strings":["CSL Behring, Med Affairs, King of Prussia, PA, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CSL Behring, Med Affairs, King of Prussia, PA, United States","institution_ids":["https://openalex.org/I4210112753"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056823066","display_name":"Eugene Maraskovsky","orcid":"https://orcid.org/0000-0003-3690-6253","observed_orcids":["https://orcid.org/0000-0003-3690-6253"]},"institutions":[{"id":"https://openalex.org/I4210153402","display_name":"CSL (Australia)","ror":"https://ror.org/044tc0x05","country_code":"AU","type":"company","lineage":["https://openalex.org/I4210153402"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"E. Maraskovsky","raw_affiliation_strings":["CSL Limited, Research, Melbourne, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"CSL Limited, Research, Melbourne, Australia","institution_ids":["https://openalex.org/I4210153402"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004538115","display_name":"John Blangero","orcid":"https://orcid.org/0000-0001-6250-5723","observed_orcids":["https://orcid.org/0000-0001-6250-5723"]},"institutions":[{"id":"https://openalex.org/I2802326326","display_name":"The University of Texas Rio Grande Valley","ror":"https://ror.org/02p5xjf12","country_code":"US","type":"education","lineage":["https://openalex.org/I2802326326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"J. Blangero","raw_affiliation_strings":["University of Texas Rio Grande Valley School of Medicine, South Texas Diabetes & Obesity Institute, Brownsville, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Rio Grande Valley School of Medicine, South Texas Diabetes & Obesity Institute, Brownsville, TX, United States","institution_ids":["https://openalex.org/I2802326326"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056308632","display_name":"Tom E. Howard","orcid":"https://orcid.org/0000-0002-4550-278X","observed_orcids":["https://orcid.org/0000-0002-4550-278X"]},"institutions":[{"id":"https://openalex.org/I2802326326","display_name":"The University of Texas Rio Grande Valley","ror":"https://ror.org/02p5xjf12","country_code":"US","type":"education","lineage":["https://openalex.org/I2802326326"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"T. Howard","raw_affiliation_strings":["University of Texas Rio Grande Valley School of Medicine, South Texas Diabetes & Obesity Institute, Brownsville, TX, United States"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Texas Rio Grande Valley School of Medicine, South Texas Diabetes & Obesity Institute, Brownsville, TX, United States","institution_ids":["https://openalex.org/I2802326326"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":3600,"currency":"USD","value_usd":3600},"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"78","issue":null,"first_page":"202","last_page":"203"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11280","display_name":"Hemophilia Treatment and Research","score":0.9955999851226807,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12576","display_name":"vaccines and immunoinformatics approaches","score":0.0013000000035390258,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12255","display_name":"Biosimilars and Bioanalytical Methods","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/factor-viii-inhibitors","display_name":"factor VIII inhibitors","score":0.6840000152587891},{"id":"https://openalex.org/keywords/hemophilia-a","display_name":"hemophilia A","score":0.9039999842643738},{"id":"https://openalex.org/keywords/recombinant-factor-viii","display_name":"recombinant factor VIII","score":0.7599999904632568},{"id":"https://openalex.org/keywords/b-domain-deleted-factor-viii","display_name":"B-domain-deleted factor VIII","score":0.7039999961853027},{"id":"https://openalex.org/keywords/endophenotypes","display_name":"endophenotypes","score":0.5849999785423279},{"id":"https://openalex.org/keywords/therapeutic-proteins","display_name":"therapeutic proteins","score":0.5}],"concepts":[{"id":"https://openalex.org/C195616568","wikidata":"https://www.wikidata.org/wiki/Q128711","display_name":"Epitope","level":3,"score":0.6378925442695618},{"id":"https://openalex.org/C2779281246","wikidata":"https://www.wikidata.org/wiki/Q172847","display_name":"Peptide","level":2,"score":0.6281900405883789},{"id":"https://openalex.org/C2777313579","wikidata":"https://www.wikidata.org/wiki/Q898365","display_name":"Glycosylation","level":2,"score":0.551151692867279},{"id":"https://openalex.org/C57409179","wikidata":"https://www.wikidata.org/wiki/Q1218293","display_name":"Lysis","level":2,"score":0.5266925096511841},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4747905135154724},{"id":"https://openalex.org/C153911025","wikidata":"https://www.wikidata.org/wiki/Q7202","display_name":"Molecular biology","level":1,"score":0.32687944173812866},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3065246343612671},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2932451367378235},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.27899670600891113},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.1400764286518097}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1016/j.humimm.2017.06.256","doi":"https://doi.org/10.1016/j.humimm.2017.06.256","is_oa":false,"landing_page_url":"https://doi.org/10.1016/j.humimm.2017.06.256","pdf_url":null,"source":{"id":"https://openalex.org/S6860681","display_name":"Human Immunology","issn_l":"0198-8859","issn":["0198-8859","1879-1166"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-3"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Human Immunology","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9537000060081482}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2560310760","https://openalex.org/W3175063500","https://openalex.org/W2889295858","https://openalex.org/W2976491981","https://openalex.org/W2942558812","https://openalex.org/W2990605769","https://openalex.org/W3095320224","https://openalex.org/W2558478587","https://openalex.org/W1594032348","https://openalex.org/W2980924351"],"abstract_inverted_index":null,"counts_by_year":[],"updated_date":"2026-10-30T12:39:25.321706","created_date":"2017-09-15T00:00:00"}